Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 283

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis

Open access
Falagas, Matthew E., Tansarli, Giannoula S., Ikawa, Kazuro, Vardakas, Konstantinos Z. · 2013 · Clinical Infectious Diseases

Abstract

We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD) properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is longer, were associated with lower mortality. PubMed and Scopus were searched for studies reporting on patients treated with extended (≥3 hours) or continuous (24 hours) versus short-term duration (20-60 minutes) infusions of carbapenems or piperacillin/tazobactam. Fourteen studies were included (1229 patients). Mortality was lower among patients receiving extended or continuous infusion of carbapenems or piperacillin/tazobactam compared to those receiving short-term (risk ratio [RR], 0.59; 95% confidence interval [CI], .41-.83). Patients with pneumonia who received extended or continuous infusion had lower mortality than those receiving short-term infusion (RR, 0.50; 95% CI, 0.26-0.96). Data for other specific infections were not available. The available evidence from mainly nonrandomized studies suggests that extended or continuous infusion of carbapenems or piperacillin/tazobactam was associated with lower mortality. Well-designed randomized controlled trials are warranted to confirm these findings before such approaches become widely used.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cis857

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 10

  1. Thiem, 2011, Elderly patients with community-acquired pneumonia: optimal treatment strategies, Drugs Aging, 28, 519, 10.2165/11591980-000000000-00000 · doi:10.2165/11591980-000000000-00000
  2. Dow, 2011, Retrospective study of prolonged versus intermittent infusion piperacillin-tazobactam and meropenem in intensive care unit patients at an academic medical center, Infect Dis Clin Pract, 19, 413, 10.1097/IPC.0b013e31822e9bf5 · doi:10.1097/ipc.0b013e31822e9bf5
  3. Itabashi, 2007, Clinical efficacy of prolonged (4 hour) drip infusion of meropenem against severe pneumonia, Japan J Antibiot, 60, 161
  4. Patel, 2009, Outcomes of extended infusion piperacillin/tazobactam for documented gram-negative infections, Diagn Microbiol Infect Dis, 64, 236, 10.1016/j.diagmicrobio.2009.03.002 · doi:10.1016/j.diagmicrobio.2009.03.002
  5. Kojika, 2005, A preliminary study of the administration of carbapenem antibiotics in sepsis patients on the basis of the administration time, Jpn J Antibiot, 58, 452
  6. Pedeboscq, 2001, Comparison of 2 administration protocols (continuous or discontinuous) of a time-dependent antibiotic, Tazocin, Pathol Biol (Paris), 49, 540
  7. Falagas, 2006, Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem, Scand J Infect Dis, 38, 807, 10.1080/00365540500504125 · doi:10.1080/00365540500504125
  8. Kim, 2009, Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia, Clin Ther, 31, 2765, 10.1016/j.clinthera.2009.11.026 · doi:10.1016/j.clinthera.2009.11.026
  9. Lee, 2010, Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation, Diagn Microbiol Infect Dis, 68, 251, 10.1016/j.diagmicrobio.2010.06.012 · doi:10.1016/j.diagmicrobio.2010.06.012
  10. Bliziotis, 2011, Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia, PLoS One, 6, e26470, 10.1371/journal.pone.0026470 · doi:10.1371/journal.pone.0026470

Cited by

See all 283

Metadata

Authors
Falagas, M. E., Tansarli, G. S., Ikawa, K., & Vardakas, K. Z.
Venue
Clinical Infectious Diseases
Published
2012-10-16
Volume
56
Issue
2
Pages
272-282
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2150263213
Cited by
283
References
45
FWCI
4.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.